Brochure | October 4, 2023

Advancing The Technologies That Smartly Scale iPSC To Benefit Human Health

Source: Cellistic
Scientist Laboratory sample pipette GettyImages-1354172647

Allogeneic cell therapies are poised to transform the cell therapy landscape. At Cellistic, we believe human induced pluripotent stem cell (iPSC)-based technologies are the future of cell therapy. By combining our experience in human biology and iPSC technologies with cell differentiation and expansion expertise, our iPSCs-based platform is engineered to propel allogeneic cell therapies to clinic with high efficiency and acuity at every step.

Learn how leveraging a GMP-like environment even in early R&D stages is crucial for setting your therapy up for success as you advance toward IND and NDA approvals. Access the right technologies and capabilities for manufacturing your product at scale and deliver effective, affordable therapy products to treat patients in need.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene